PTEN-deficient PCa cells such as LNCaP are targeted directly or indirectly to restore PTEN function, via the blockade of the PI3KT/AKT pathway in combination with chemotherapy and other drugs [192,193]. The gene discussed is PTEN; the disease is posterior cortical atrophy.